卡介苗复种及预防性服药对某高校肺结核患病情况的影响  

The Effect of BCG Revaccination and Prophylactic Chemotherapy on Epidemic Situation of Pulmonary Tuberculosis of a University

作　　者：缪梓萍[1] 王乐[2] 

机构地区：[1]浙江省杭州市西湖区疾病预防控制中心,310013 [2]杭州市疾病预防控制中心

出　　处：《中国学校卫生》2002年第5期407-407,412,共2页Chinese Journal of School Health

摘　　要：目的　评价卡介苗 (BCG)复种效果和预防性服药的流行病学意义。方法　采取回顾性调查的方法 ,对BCG复种及预防性服药停止前后的肺结核疫情进行分析。结果　BCG复种和预防性服药停止后学生肺结核发病率降低。结论　PPD强阳性者预防服药对控制高校结核病疫情未见流行病学方面的作用 ;BCG复种没有额外的保护作用 。Objective To evaluatee the effect of BCG revaccination and the epidemiological significance of prophylactic chemotherapy.Methods A retrospective investigation method was used to analysis the epidemic situation of pulmonary tuberculosis before and after BCG revaccination and prophylactic chemotherapy. Results The prevalence rate of pulmonary tuberculosis among the surveyed university students reduced after BCG revaccination and prophylactic chemotherapy.Conclusions Prophylactic chemotherapy for students with PPD strong positive reaction has no obvious effect on the control of the epidemic situation of pulmonary tuberculosis in the university. BCG revaccination has no additional protective effect, further emphasis should focus on if it could induce the onset of latent infection.

关 键 词：卡介苗 复种 预防性服药 高校 肺结核 

分 类 号：R521[医药卫生—内科学] R186.2[医药卫生—临床医学]